Nasdaq Biotechnology Ishares (IBB) News 229.38 $IBB
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 2.86% Sell Off
Comtex SmarTrend(R) - Fri Mar 28, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $228.69 to a high of $238.54. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $228.72 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.86% Loss
Comtex SmarTrend(R) - Fri Mar 28, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $228.69 to a high of $238.54. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $228.72 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Poof! Biotech's 2014 Outperformance is Gone
at The Street - Fri Mar 28, 3:16PM CDT
Biotech stocks continue to melt down. I know, broken record, but like a car wreck, it's hard not to look.
A Speculative Biotech Catalyst Trade: ORMP
at The Street - Fri Mar 28, 8:23AM CDT
This beaten-down biotech stock could be ripe for a rebound.
3 Biotechs Falling Like a Knife: Arrowhead, Celldex, Receptos
George Budwell, The Motley Fool - Motley Fool - Wed Mar 26, 5:30PM CDT
By all accounts, biotech has had a rough week. The iShares Nasdaq Biotechnology Index is down more than 8%, and concerns over a bubble abound. Yet some companies are falling much faster than the broader sector. Are these companies becoming value...
A Small-Cap Biotech Stock With Promise: MSTX
at The Street - Wed Mar 26, 1:55PM CDT
This small-cap biotech stock could be setting up for a great buying opportunity here following the massive selloff in the space.
iShares Nasdaq Biotechnology Index Fund (IBB) : Take profit @ $241.55
Trading Central - Wed Mar 26, 8:48AM CDT
The ETF is challenging its rising 20-week moving average which is acting as a support; we prefer to take profit right now at last price on short position opened on March 21st (+5.27%). Trading strategy: Close our short position at last price...
Why We're Watching This Biotech Index
Chris Hill, The Motley Fool - Motley Fool - Wed Mar 26, 8:30AM CDT
In this segment from Tuesday's Investor Beat , Motley Fool analyst Morgan Housel discusses the iShares NASDAQ Biotechnology Index , and why he sees many tell-tale red flags that the biotech space is in a bubble right now. Morgan gives his insight...
1 Big Reason to Doubt the Biotech Bubble Chorus
Keith Speights, The Motley Fool - Motley Fool - Wed Mar 26, 8:30AM CDT
Raise your hand if you've heard the words "biotech" and "bubble" used in the same sentence recently. Observers from virtually every corner have joined the chorus singing the blues about the biotech sector. Some might even be humming a funeral dirge....
Investor Beat: JPMorgan's CEO Succession Chain Uncertain?
Chris Hill, The Motley Fool - Motley Fool - Tue Mar 25, 6:26PM CDT
The Dow and S&P bounced back today, despite the latest round of housing data, which showed that new home sales fell 3.3% for the month of February, hitting a five-month low. On Tuesday's edition of Investor Beat , host Chris Hill and Motley...
Best Buys for a Biotech Bubble
David Williamson, The Motley Fool - Motley Fool - Tue Mar 25, 5:58PM CDT
There has been a lot of buzz in recent days about the idea of a bubble in the biotech space on the market today. The iShares NASDAQ Biotechnology Index , an ETF that tracks a range of companies in the biotech space, peaked exactly a month ago, and...
'Fast Money' Recap: The Value of 'Old Tech' Stocks
at The Street - Tue Mar 25, 4:00AM CDT
The trading panel discussed why these stocks have solid upside momentum and reasonable valuations.
How Herbalife and Nu Skin Escaped Today's Health-Care Stock Bloodbath
David Williamson, The Motley Fool - Motley Fool - Mon Mar 24, 4:35PM CDT
In today's look at the winners and losers in health care and biotech, the biggest story is the losses across the board in biotech stocks. The iShares Biotechnology Index sold off 3% today, as talk of a biotech bubble increases and concerns over...
Are Biotech Stocks Oversold? - Analyst Blog
Brian Hamilton - Zacks Investment Research - Mon Mar 24, 3:26PM CDT
The street is not too concerned about the recent expected correction.
Don't Hate Josh Brown For Calling Biotech a Bubble. Learn From Him.
at The Street - Mon Mar 24, 3:17PM CDT
If you want to understand why your beloved biotech stocks are tanking, you must read Brown's blog post right now. Hell, if you already read Brown's post earlier today, read it again.
3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Mar 24, 1:00PM CDT
The terrible trading in the biotech stock world sent these ETFs into deep red in Friday session.
Another Bad Day in Biotech Stocks, Pace of Selling Accelerates
at The Street - Mon Mar 24, 10:21AM CDT
Bubble or not, biotech stocks have been weak all March, erasing gains made in February.
Why Johnson & Johnson Should Be in Your Portfolio
George Budwell, The Motley Fool - Motley Fool - Sun Mar 23, 2:30PM CDT
The red-hot health-care sector has started cooling off. Over the past month, the iShares Nasdaq Biotechnology Index has fallen 7.33%, and last Friday saw the sector's biggest single day loss in recent memory. Although this near 5% drop was...
'Fast Money' Recap: A Down Day
at The Street - Sat Mar 22, 4:00AM CDT
The trading panel discussed how investors are rotating out of high-growth stocks and into stocks like Microsoft and Cisco.
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 2.86% Sell Off
Comtex SmarTrend(R) - Fri Mar 28, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $228.69 to a high of $238.54. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $228.72 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.86% Loss
Comtex SmarTrend(R) - Fri Mar 28, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $228.69 to a high of $238.54. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $228.72 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Poof! Biotech's 2014 Outperformance is Gone
at The Street - Fri Mar 28, 3:16PM CDT
Biotech stocks continue to melt down. I know, broken record, but like a car wreck, it's hard not to look.
A Speculative Biotech Catalyst Trade: ORMP
at The Street - Fri Mar 28, 8:23AM CDT
This beaten-down biotech stock could be ripe for a rebound.
3 Biotechs Falling Like a Knife: Arrowhead, Celldex, Receptos
George Budwell, The Motley Fool - Motley Fool - Wed Mar 26, 5:30PM CDT
By all accounts, biotech has had a rough week. The iShares Nasdaq Biotechnology Index is down more than 8%, and concerns over a bubble abound. Yet some companies are falling much faster than the broader sector. Are these companies becoming value...
A Small-Cap Biotech Stock With Promise: MSTX
at The Street - Wed Mar 26, 1:55PM CDT
This small-cap biotech stock could be setting up for a great buying opportunity here following the massive selloff in the space.
iShares Nasdaq Biotechnology Index Fund (IBB) : Take profit @ $241.55
Trading Central - Wed Mar 26, 8:48AM CDT
The ETF is challenging its rising 20-week moving average which is acting as a support; we prefer to take profit right now at last price on short position opened on March 21st (+5.27%). Trading strategy: Close our short position at last price...
Why We're Watching This Biotech Index
Chris Hill, The Motley Fool - Motley Fool - Wed Mar 26, 8:30AM CDT
In this segment from Tuesday's Investor Beat , Motley Fool analyst Morgan Housel discusses the iShares NASDAQ Biotechnology Index , and why he sees many tell-tale red flags that the biotech space is in a bubble right now. Morgan gives his insight...
1 Big Reason to Doubt the Biotech Bubble Chorus
Keith Speights, The Motley Fool - Motley Fool - Wed Mar 26, 8:30AM CDT
Raise your hand if you've heard the words "biotech" and "bubble" used in the same sentence recently. Observers from virtually every corner have joined the chorus singing the blues about the biotech sector. Some might even be humming a funeral dirge....
Investor Beat: JPMorgan's CEO Succession Chain Uncertain?
Chris Hill, The Motley Fool - Motley Fool - Tue Mar 25, 6:26PM CDT
The Dow and S&P bounced back today, despite the latest round of housing data, which showed that new home sales fell 3.3% for the month of February, hitting a five-month low. On Tuesday's edition of Investor Beat , host Chris Hill and Motley...
Best Buys for a Biotech Bubble
David Williamson, The Motley Fool - Motley Fool - Tue Mar 25, 5:58PM CDT
There has been a lot of buzz in recent days about the idea of a bubble in the biotech space on the market today. The iShares NASDAQ Biotechnology Index , an ETF that tracks a range of companies in the biotech space, peaked exactly a month ago, and...
'Fast Money' Recap: The Value of 'Old Tech' Stocks
at The Street - Tue Mar 25, 4:00AM CDT
The trading panel discussed why these stocks have solid upside momentum and reasonable valuations.
How Herbalife and Nu Skin Escaped Today's Health-Care Stock Bloodbath
David Williamson, The Motley Fool - Motley Fool - Mon Mar 24, 4:35PM CDT
In today's look at the winners and losers in health care and biotech, the biggest story is the losses across the board in biotech stocks. The iShares Biotechnology Index sold off 3% today, as talk of a biotech bubble increases and concerns over...
Are Biotech Stocks Oversold? - Analyst Blog
Brian Hamilton - Zacks Investment Research - Mon Mar 24, 3:26PM CDT
The street is not too concerned about the recent expected correction.
Don't Hate Josh Brown For Calling Biotech a Bubble. Learn From Him.
at The Street - Mon Mar 24, 3:17PM CDT
If you want to understand why your beloved biotech stocks are tanking, you must read Brown's blog post right now. Hell, if you already read Brown's post earlier today, read it again.
3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Mar 24, 1:00PM CDT
The terrible trading in the biotech stock world sent these ETFs into deep red in Friday session.
Another Bad Day in Biotech Stocks, Pace of Selling Accelerates
at The Street - Mon Mar 24, 10:21AM CDT
Bubble or not, biotech stocks have been weak all March, erasing gains made in February.
Why Johnson & Johnson Should Be in Your Portfolio
George Budwell, The Motley Fool - Motley Fool - Sun Mar 23, 2:30PM CDT
The red-hot health-care sector has started cooling off. Over the past month, the iShares Nasdaq Biotechnology Index has fallen 7.33%, and last Friday saw the sector's biggest single day loss in recent memory. Although this near 5% drop was...
'Fast Money' Recap: A Down Day
at The Street - Sat Mar 22, 4:00AM CDT
The trading panel discussed how investors are rotating out of high-growth stocks and into stocks like Microsoft and Cisco.
